European Journal of Internal Medicine
Volume 20, Issue 5 , Pages 482-486 , September 2009

Homocysteine and endothelial markers are increased in patients with chronic liver diseases

  • Anna Remková

      Affiliations

    • Department of Internal Medicine, Military Hospital, Bratislava, Slovak Republic
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, Military Hospital, Cesta na Červený most 1, SK-833 31 Bratislava, Slovak Republic. Tel.: +421 2 59351 163; fax: +421 2 59351 161.
    • ,
  • Milan Remko

      Affiliations

    • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Bratislava, Slovak Republic

Received 20 September 2008 ,Revised 4 January 2009 ,Accepted 4 March 2009.

References 

  1. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015–2022
  2. Bautista LE, Arenas IA, Penuela A, Martinez LX. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol. 2002;55:882–887
  3. Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS. Plasma total homocysteine and cardiovascular and non-cardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr. 2002;74:130–136
  4. Herrero JI, Quiroga J, Sangro B, Beloqui O, Pardo F, Cienfuegos JA, et al. Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors. Liver Transplant. 2000;6:614–618
  5. Garcia-Tevijano ER, Berasain C, Rodríguez JA, Corrales FJ, Arias R, Martín-Duce A, et al. Hyperhomocysteinemia in liver cirrhosis. Mechanism and role in vascular and hepatic fibrosis. Hypertension. 2001;38:1217–1221
  6. Clarke R, Stansbie D. Assessment of homocysteine as a cardiovascular risk factor in clinical practice. Ann Clin Biochem. 2001;38:624–632
  7. Child CG, Turcotte JG. Surgery and portal hypertension. In:  Child CG editors. The liver and portal hypertension. Philadelphia: WB Saunders; 1964;p. 50–51
  8. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocysteine with the Abbot IMx® analyzer. Clin Chem. 1995;41:991–994
  9. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50:3–32
  10. Ferré N, Gómez F, Camps J, Simó JM, Murphy MM, Fernández-Ballart J, et al. Plasma homocysteine concentrations in patients with liver cirrhosis. Clin Chem. 2002;48:183–185
  11. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine induced endoplasmic reticulum stress causes. J Clin Invest. 2001;107:1263–1273
  12. Ben-Ari Z, Tur-Kaspa R, Schafer Z, Baruch Y, Sulkes J, Atzmon O, et al. Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease. J Investig Med. 2001;49:325–329
  13. Lambert D, Benhayoun S, Adjalla C, Gelot MM, Renkes P, Gerard P, et al. Alcoholic cirrhosis and cobalamin metabolism. Digestion. 1997;58:64–71
  14. Look MP, Riezler R, Reichel C, Brensing KA, Rockstroh JK, Stabler SP, et al. Is the increase in serum cystathione levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase?. Scand J Gastroenterol. 2000;35:866–872
  15. Bosy-Westphal A, Petersen S, Hinrichsen H, Czech N, Muller M. Increased plasma homocysteine in liver cirrhosis. Hepatol Res. 2001;20:28–38
  16. De la Vega MJ, Santolaria F, González-Reimers E, Alemán MR, Milena A, Martinez-Riera A, et al. High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylentetrahydrofolate reductase (MTHFR). Alcohol. 2001;25:59–67
  17. Marsui T, Arzai H, Yuzuriha T. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke. 2001;32:1116–1119
  18. Halsted CH, Villanueva JA, Devlin AM. Folate deficiency, methionine metabolism, and alcoholic liver disease. Alcohol. 2002;27:169–172
  19. Kornhuber HH. Prevention of dementia (including Alzheimer's disease). Gesundheitswesen. 2004;66:346–351
  20. Blasco C, Cballeria J, Deulofeu R, Lligona A, Parés A, Lluis JM, et al. Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics. Alcohol Clin Exp Res. 2005;29:1044–1048
  21. Mennen LI, de Courcy GP, Guilland JC, Ducros V, Zaebska M, Bertrais S, et al. Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr. 2003;78:334–338
  22. Vollset SE, Nygard OGK, Ueland PM, Refsum H. The Hordaland homocysteine study: lifestyle and plasma homocysteine in Western Norway. In:  Graham I,  Refsum H,  Rosenberg IH,  Ueland PM editor. Homocysteine metabolism: from basic science to clinical medicine. Norwell, MA: Kluwer Academic Publishers; 1997;p. 177–182
  23. Koehler KM, Baumgartner RN, Garry PJ, Allen RH, Stabler SP, Rimm EB. Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use. Am J Clin Nutr. 2001;73:628–637
  24. Mayer O, Simon J, Rosolová H. A population study on the influence of beer consumption on folate and homocysteine concentrations. Eur J Clin Nutr. 2001;55:605–609
  25. De Luis DA, Fernandez N, Aller R, De Luis J, Arranz M, Izaola O. Relation between total homocysteine levels and beer intake in patients with diabetes mellitus type 2. Ann Nutr Metab. 2003;47:119–123
  26. Nappo F, De Rosa N, Marfella R, De Lucia D, Ingrosso D, Perna AF, et al. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA. 1999;281:2113–2118
  27. Okumura K, Aso Y. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy. Metabolism. 2003;52:1517–1522
  28. Spencer CG, Martin SC, Felmeden DC, Blann AD, Beevers GD, Lip GY. Relationship of homocysteine to markers of platelet and endothelial activation in “high risk” hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Int J Cardiol. 2004;94:293–300

☆ This is to state that there is no conflict of interest in relation to this work.

PII: S0953-6205(09)00044-2

doi: 10.1016/j.ejim.2009.03.002

European Journal of Internal Medicine
Volume 20, Issue 5 , Pages 482-486 , September 2009

Article Tools

* Image Usage & Resolution